1. Home
  2. FBIO vs VANI Comparison

FBIO vs VANI Comparison

Compare FBIO & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$3.37

Market Cap

113.6M

Sector

Health Care

ML Signal

HOLD

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.30

Market Cap

116.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBIO
VANI
Founded
2006
1998
Country
United States
United States
Employees
78
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
113.6M
116.4M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
FBIO
VANI
Price
$3.37
$1.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$17.00
$3.50
AVG Volume (30 Days)
611.0K
624.4K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,000,000.00
Revenue This Year
$55.22
N/A
Revenue Next Year
$40.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.77
$0.92
52 Week High
$4.53
$1.92

Technical Indicators

Market Signals
Indicator
FBIO
VANI
Relative Strength Index (RSI) 58.98 50.06
Support Level $3.28 $1.17
Resistance Level $3.80 $1.34
Average True Range (ATR) 0.22 0.12
MACD 0.03 -0.00
Stochastic Oscillator 59.46 26.00

Price Performance

Historical Comparison
FBIO
VANI

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

Share on Social Networks: